Café

© 2026 Longbridge｜Terms of Service Privacy Policy

688336

688336

47.651.97%( -0.96 )

LongbridgeAI

Sunshine Guojian Pharmaceutical: The company's restructured anti-IL-1β humanized monoclonal antibody injection new drug application has been accepted

Wallstreetcn

Jun 5, 2025 at 05:47 AM

Sunshine Guojian Pharmaceutical: The company's restructured anti-IL-1β humanized monoclonal antibody injection new drug application has been accepted

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Sunshine Guojian Pharmaceutical

688336.SH

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--